Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3025]

The future potential of cannabis in healthcare

Prof Henry Lowe - CEO Medicanja, Kingston, Jamaica

The future potential of cannabis in healthcare ( Prof Henry Lowe - CEO Medicanja, Kingston, Jamaica )

Training medical physics in developing countries

Prof. Golam Abu Zakaria - Gummersbach Hospital, University of Cologne, Cologne...

Training medical physics in developing countries ( Prof. Golam Abu Zakaria - Gummersbach Hospital, University of Cologne, Cologne, Germany )

Driving the medicinal cannabis industry

Minister Audley Shaw - Minister of Industry, Commerce, Agriculture and...

Driving the medicinal cannabis industry ( Minister Audley Shaw - Minister of Industry, Commerce, Agriculture and Fisheries, Jamaica )

Running a cancer hospital in rural Cameroon

Dennis Palmer - CIMP Program Director, Mbingo Baptist Hospital, Cameroon

Running a cancer hospital in rural Cameroon ( Dennis Palmer - CIMP Program Director, Mbingo Baptist Hospital, Cameroon )

Genomic trends across the African Diaspora for breast cancer

Prof Melissa B Davis - Weill Cornell Medical College, New York, USA

Genomic trends across the African Diaspora for breast cancer ( Prof Melissa B Davis - Weill Cornell Medical College, New York, USA )

The latest advances from BioVentures for Global Health in Africa

Jennifer Dent - BioVentures for Global Health, Seattle, USA

The latest advances from BioVentures for Global Health in Africa ( Jennifer Dent - BioVentures for Global Health, Seattle, USA )

Highlights from ASCO 2019

Asst. Prof Bishal Gyawali and Monique Biryiana

Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )

New agent targeting Nectin-4 produces responses in nearly half of patients with...

Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA

New agent targeting Nectin-4 produces responses in nearly half of patients with advanced urothelial cancer ( Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA )

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer...

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer with focus on intermediate IMDC-risk population ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

Enzalutamide as treatment for men with mHSPC who have received testosterone...

Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Enzalutamide as treatment for men with mHSPC who have received testosterone suppression ( Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

Enzalutamide improves survival for men with metastatic hormone-sensitive...

Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer ( Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

Comment: Using enzalutamide will allow patients to avoid chemotherapy and...

Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA

Comment: Using enzalutamide will allow patients to avoid chemotherapy and steroids improving quality of life ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA )

More from ecancer